PMO Interview with the Innovator Series: Volume 4
Thomas C. Reynolds, MD, PhD
Video Categories: PMO Interview with the Innovator Series
Jennifer R. Brown, MD, PhD, at Dana-Farber Cancer Institute in Boston, discusses what she believes are the most important items coming out of ASH for CLL this year. She mentions excellent study results being presented about the drugs ibrutinib and ABT199.
Hear as Dr Agarwala deliberates the impact of the Affordable Care Act on oncology care.